Leonard Reid 4
4 · Werewolf Therapeutics, Inc. · Filed Jan 18, 2022
Insider Transaction Report
Form 4
Leonard Reid
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-06+70,967→ 70,967 totalExercise: $11.55Exp: 2032-01-05→ Common Stock (70,967 underlying)
Footnotes (1)
- [F1]The option was granted on January 6, 2022 with a Vesting Commencement Date of January 1, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through January 1, 2026.